Literature DB >> 8665789

Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease.

M Castro1, M J Krowka.   

Abstract

Hepatopulmonary syndrome is part of the spectrum of pulmonary vascular disorders seen in advanced liver disease. The pathophysiology of these entities likely is dependent on the degree of pulmonary vasoconstriction or vasodilation that occurs. Our understanding of hepatopulmonary syndrome has helped further our knowledge of the interaction of the liver and the lung. Advances in the management of this disorder, especially liver transplantation, finally have allowed us to offer some hope to patients with this disease.

Entities:  

Mesh:

Year:  1996        PMID: 8665789     DOI: 10.1016/s0272-5231(05)70297-5

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  27 in total

1.  Effects of caffeic acid phenethyl ester (CAPE) on hepatopulmonary syndrome.

Authors:  Ahmet Tekin; Serdar Türkyılmaz; Tevfik Küçükkartallar; Murat Cakır; Hüseyin Yılmaz; Hasan Esen; Burhan Ateş; Ilhan Ciftci; Adil Kartal
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

2.  [Hepatopulmonary syndrome].

Authors:  G P Glattki; C Maurer; N Satake; R Lange; K Metz; M Wettstein; U Costabel
Journal:  Med Klin (Munich)       Date:  1999-09-15

3.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

4.  Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography.

Authors:  R Aller; J L Moya; V Moreira; D Boixeda; A Cano; J Picher; S García-Rull; D A de Luis
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

5.  Onset ages of hepatopulmonary syndrome and pulmonary hypertension in patients with biliary atresia.

Authors:  Takehisa Ueno; Ryuta Saka; Yuichi Takama; Hiroaki Yamanaka; Yuko Tazuke; Kazuhiko Bessho; Hiroomi Okuyama
Journal:  Pediatr Surg Int       Date:  2017-09-04       Impact factor: 1.827

6.  Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.

Authors:  P Schenk; V Fuhrmann; C Madl; G Funk; S Lehr; O Kandel; C Müller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following liver transplantation.

Authors:  Geoffrey M Fleming; Timothy T Cornell; Theodore H Welling; John C Magee; Gail M Annich
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

8.  Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients.

Authors:  Sabahattin Kaymakoglu; Tevfik Kahraman; Hasan Kudat; Kadir Demir; Yilmaz Cakaloglu; Isik Adalet; Dinc Dincer; Fatih Besisik; Güngör Boztas; Ahmet Bilge Sözen; Zeynel Mungan; Atilla Okten
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

9.  Sarcoidosis complicated by cirrhosis and hepatopulmonary syndrome.

Authors:  Samir Gupta; Marie E Faughnan; Gerald J Prud'homme; David M Hwang; David G Munoz; Peter Kopplin
Journal:  Can Respir J       Date:  2008-04       Impact factor: 2.409

10.  Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia.

Authors:  Hui-Ying Zhang; De-Wu Han; Zhong-Fu Zhao; Ming-She Liu; Yan-Jun Wu; Xian-Ming Chen; Cheng Ji
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.